The cytoplasmic domain of the common b-chain (bc) of the granulocyte-macrophage-colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3)/IL-5 receptor contains a membrane proximal region that is sufficient to mediate ligand-dependent mitogenic activity. Within this region two motifs, designated as box 1 and box 2, are highly conserved among members of the cytokine receptor superfamily. Whereas box 1 is required for the recruitment and phosphorylation of Janus kinase-2, the function of box 2 remains largely unknown. Here, we report the identification of a novel transmembrane protein (common b-chain associated protein (CBAP)) which directly associated with bc via the box 2 motif. Interestingly, such an association only occurred in the absence of GM-CSF in vivo. Ectopic overexpression of CBAP triggered apoptosis of factor-dependent cells via mitochondrial dysfunction, which could be inhibited by Bcl-2 overexpression. Reduced expression of endogenous CBAP by small interfering RNA did not interfere GM-CSF-activated signaling molecules, but such treatment significantly inhibited apoptosis induced by GM-CSF deprivation, but not other death stimuli. Domain mapping studies indicated that one apoptogenic domain of CBAP correlated with its ability to interact with bc. Taken together, these results suggest that CBAP modulates GM-CSF-deprivation-induced apoptosis possibly via a novel mechanism involving interaction with an un-liganded bc molecule.
Introduction
Granulocyte-macrophage-colony stimulating factor (GM-CSF) regulates growth, death, motility and differentiation of hematopoietic progenitors and granulocytes. It binds to a high-affinity receptor composed of a GM-CSF-specific a-chain (Gearing et al., 1989 ) and a signal transducer common b-chain (bc), which is shared with the receptors for interleukin-3 (IL-3) and IL-5 (Kitamura et al., 1991; Tavernier et al., 1991) . Binding of GM-CSF to its receptors induces the rapid tyrosine phosphorylation of both a constellation of cellular proteins and the bc (Sakamaki et al., 1992) . Analysis of various deletion mutants of bc revealed that the membrane proximal region is required for growth signals (Sakamaki et al., 1992) , induction of c-myc and pim-1 (Sato et al., 1993) and activation of Janus kinase-2 (JAK2) (Quelle et al., 1994) . Whereas, the membrane distal region is essential for tyrosine phosphorylation of many signaling adaptors (Sakamaki et al., 1992) , activation of the Ras/Raf-1/MAP kinase/S6 kinase and phosphoinositide-3 kinase pathways (Sato et al., 1993) , induction of c-fos and c-jun (Sato et al., 1993) , and antiapoptotic activity (Kinoshita et al., 1995) .
Two stretches of amino acids designated as box 1 and box 2 in the membrane proximal region of the receptor bc-subunit are highly conserved among many members of the cytokine receptor superfamily. The box 1 motif comprises a P-X-P sequence and a preceding cluster of hydrophobic amino acids (Murakami et al., 1991) and is responsible for association and activation of JAK (Argetsinger et al., 1993; Witthuhn et al., 1993; Tanner et al., 1995) . The box 2 motif includes both a cluster of hydrophobic amino acids and some negatively charged amino acids embedded within these hydrophobic residues (Murakami et al., 1991) . Although earlier studies suggest that the box 2 motif is essential for transducing mitogenic signals for gp130 (Murakami et al., 1991; Miura and Ihle, 1993) , erythropoietin (Murakami et al., 1991; Miura and Ihle, 1993) and thrombopoietin receptors (Drachman et al., 2002) , the underlying mechanism for such functions remain elusive. In this study, by the yeast two-hybrid screening approach, we identified a novel protein designated as common b-chain associated protein (CBAP) that binds to the box 2 motif of the receptor bc-subunit. Surprisingly, CBAP is a proapoptotic protein and may mediate apoptotic signaling via interaction with the un-liganded bc molecule.
Results
Identification of a bc box 2-associated protein, CBAP To examine the role of the box 2 motif in the signaling events transduced by the bc-subunit of the GM-CSF/ IL-3/IL-5 receptor, we searched for bc-box 2 interacting proteins via the yeast two-hybrid screen. For this experiment, the peptide fragment of bc (amino acids 506-560) containing the box 2 motif was used as bait to screen the human lymphocyte cDNA library. One clone repeatedly identified (GenBank accession number NM_178518.2) turned out to encode a hypothetical transmembrane protein, which was designated as 'common b-chain associated protein (CBAP)' (Supplementary Figure  S1a) . GST pull-down and co-immunoprecipitation (co-IP) assays confirmed that CBAP directly interacts with the box 2, but not box 1 motif of bc (Supplementary Figures S1 and S2 ).
CBAP is a membrane protein and associates with bc in the absence of cytokine CBAP is highly conserved among mammals (Supplementary Figure S3 ) and is predicted to be a type I transmembrane protein. For this study, a monoclonal antibody (mAb), 5E1, specifically recognizing an extracellular epitope of CBAP has been developed (Supplementary Figure S4) . Immunostaining of non-permeabilized TF-1 with 5E1 revealed that, like bc (Figure 1d ), some CBAP molecules are localized at the cell surface (Figure 1b) , although majority of them seem to reside in the intracellular compartments (see Figure 2c below). The surface staining signals of CBAP are specific, as they can be specifically blocked by the peptide antigen used to raise 5E1 (Figure 1c) .
Given that the association of receptor binding signaling molecules with the receptor is frequently under the regulation of ligand binding, we next examined whether the interaction between endogenous CBAP and bc is regulated by GM-CSF. To address this issue, we first carried out the co-immunoprecipitation experiment using cell lysates from TF-Bcl2 cells cultured in medium with (GM þ ) or without GM-CSF for 24 h (GMÀ). As shown in Figure 2a , removal of GM-CSF greatly enhanced the amounts of bc to be co-immunoprecipitated by the CBAP mAb 5E1 (compare lanes 3 and 6), a result that is in sharp contrast with that of JAK2, which is known to be associated with and activate bc in a GM-CSF-dependent manner (Figure 2b , compare lanes 3 and 4). Next, we employed the immuno-colocalization assay to address the same issue. In this assay, permeabilized TF-1 cells cultured in the presence or absence of GM-CSF were stained with antibodies specific to bc and CBAP and visualized by confocal microcopy. Surprisingly, under such conditions, most bc and CBAP staining signals were found to be localized in the intracellular compartments (Figure 2c ), which were quite distinct from the cell-surface staining patterns when cells were analysed but under non-permeabilized conditions (Figure 1) . Nevertheless, the bc and CBAP were rarely colocalized when cells were grown in the presence of GM-CSF (Figure 2c , GM þ ). However, colocalization of these two proteins was significantly enhanced in cells cultured without GM-CSF (Figure 2c , GMÀ). Quantification of these colocalized signals revealed that, in the presence of GM-CSF, only 5% of bc and 10% of CBAP were colocalized (Figure 2d , GM þ ). In contrast, 15% of bc and 20% of CBAP were colocalized after 24 h culture in the GM-CSF-free medium (Figure 2d , GMÀ). The difference between the percentages of colocalized bc and CBAP in medium with or without GM-CSF is highly significant (n>100 cells; Po0.0005). Taken together, these results indicate that removal of GM-CSF greatly enhances the interaction between bc and CBAP.
CBAP induces apoptosis in factor-dependent cells via a mitochondria-dependent pathway Given that the CBAP-bc interaction is greatly enhanced in the absence of GM-CSF, we next examined whether ectopic overexpression of CBAP would induce apoptosis of factor-dependent cell lines. To facilitate the identification of cells transiently overexpressing CBAP, CBAP was expressed either along with GFP using a bicistronic vector (CIG) or as a CBAP-GFP fusion protein (CG) Figure 3e ). Of note, all these apoptotic responses could be markedly prevented by overexpression of the antiapoptotic protein Bcl-2 in TF-1 cells, wherein cytokine withdrawal-induced apoptosis also could be dramatically suppressed (Figures 3d and e, CG/TF-Bcl2 vs CG/TF), suggesting that CBAP-induced cell death is mediated through a mitochondria-dependent pathway.
Reduced expression of CBAP selectively alleviates GM-CSF withdrawal-induced apoptosis Given that overexpression of CBAP induces apoptosis of TF-1 cells cultured in GM-CSF, we next examined whether CBAP plays a role in GM-CSF withdrawalinduced cell death of these cells. To address this issue, GM-CSF-deprivation-induced apoptosis was compared between TF-1 cells transfected with control (siCtrl) or CBAP-specific small interfering RNAs (siRNAs) (siCBAP or siCBAP-2). As shown in Figure 4 , more than 90% of CBAP expression could be specifically suppressed by treatment of cells with either siCBAP or siCBAP-2, compared with control siRNA (panels a and b). Notably, under such conditions, TF-1 cells with reduced amounts of CBAP were significantly more resistant to GM-CSF-deprivation-induced apoptosis than control cells (Figures 4c and 5a) . However, interestingly, knockdown of CBAP did not significantly affect TF-1 cells' sensitivity to many other apoptotic inducers including tumor necrosis factor-a, ultraviolet, actinomycin D, camptothecin, etoposide and staurosporin (Figure 5a ). Together, these results suggest that CBAP is selectively involved in GM-CSF deprivation, but not other death stimuli-induced apoptosis. The preferential interaction of CBAP with nonliganded bc prompted us to examine whether CBAP might interfere with GM-CSF activated, bc-transduced growth signaling pathways. To address this issue, we examined whether knockdown of CBAP expression would affect GM-CSF-induced activation (phosphorylation) of JAK2, Stat5 and ERK1/2, three characteristic signaling molecules that are involved in bc-transduced proliferation and/or survival signals. As shown in Figure 5b , following GM-CSF stimulation (5-20 min), no significant difference in phosphorylation of JAK2 (top panel), Stat5 (middle panel) or ERK1/2 (bottom panel) could be observed between control or CBAPspecific siRNA-treated TF-1 cells, suggesting that CBAP is not required for the normal signaling of GM-CSF.
Last, we generated various deletion mutants of CBAP (Figure 6a ) to map the protein domains required for CBAP's apoptogenic activity or interaction with bc. From analysis shown in Figure 6a , two minimum domains designated as 'apoptotic domain 1' (AD1) and 'apoptotic domain 2' (AD2), encoded by the M5 and M8 mutants, respectively, were found to have apoptogenic activities (lanes 7 and 10). Interestingly, the hinge region between AD1 and AD2 (lane 8, M6) did not manifest any activity itself. However, it appeared to inhibit the apoptotic activity of AD1 but not that of AD2 (compare lanes 6, 7, 9 and 10). Next, the coimmunoprecipitation experiment shown in Figure 6b revealed that AD1 did not interact with bc (lane 4, M5). Neither was it required for the full bc-binding activity of CBAP (lane 2, M1). Interestingly, AD2 itself bound to bc weakly (B19% of wt, compare lanes 1 and 7 of Figure 6b ). However, its affinity to bc was greatly enhanced by the hinge region between AD1 and AD2 (M7 vs M8 and M1 vs M2, Figure 6b ), which itself did not bind to bc at all (lane 6). Together, these results suggest that both AD2 and its neighboring hinge region described above constitute a complete bc-binding domain (RBD) and that association with bc may be involved in regulation of CBAP-induced apoptosis.
Discussion
In this study, we report the identification of a novel transmembrane protein CBAP that specifically interacts with the box 2 motif of the un-liganded bc molecule. We further demonstrate that CBAP plays an important role in GM-CSF removal-induced apoptosis. Despite the detailed mechanism of CBAP-induced apoptosis is not clear, the following observations strongly suggest that CBAP induces cell death via a novel mechanism involving interaction with un-liganded bc. First, association of CBAP with bc was only observed in the absence of GM-CSF. Second, GM-CSF withdrawalinduced apoptosis is sensitive to the levels of CBAP, that is, enhanced by increased, but attenuated by reduced expression of CBAP. Third, overexpression of bc enhances GM-CSF withdrawal-induced apoptosis, and the minimum death enhancement region of bc was mapped to amino acids 506-560 (Lee et al., 1999) , a region that was found to interact with CBAP in this study. Furthermore, our findings that one of the apoptotic domain of CBAP was mapped to the same region required for GM-CSF receptor association ( Figure 6 ) again support the notion that CBAP-bc interaction triggers a novel signaling pathway that leads to mitochondria dysfunction and cellular apoptosis.
Immunostaining analysis of bc and CBAP in cells with or without prior treatment with permeabilizing agent indicated that majority of these two proteins are located in intracellular vesicles, and only a small fraction of them is found on the plasma membrane. Given that the bc-CBAP interaction was only observed in the absence of GM-CSF and that, in the presence of GM-CSF, the high-affinity GM-CSF receptor (a-and bc-subunit together) transduces proliferation signals (Kitamura et al., 1991) , we propose that the membrane bc containing complexes exist in two distinct forms, the 'P' form, which contains GM-CSF receptor a-chain and is formed in the presence of GM-CSF; and the 'A' form, which contains CBAP and is formed in the absence of GM-CSF. The 'P' form complex transduces signals that lead to cellular proliferation, whereas the 'A' form transduces signals that lead to mitochondria dysfunction and cellular apoptosis (Figure 7) . It is not clear how the 'A' complex activates apoptotic signals and how they are switched from one type to the other by addition or removal of GM-CSF. Given that Jak2 was shown to bind to the box 1 motif of bc (Quelle et al., 1994) , which is in the vicinity of the CBAP-binding site, the possibility exists that GM-CSF-induced activation of JAK2 may trigger dissociation of the CBAP-bc complex and promote the formation of the 'P' form complex. However, our preliminary data did not seem to favor this possibility, because inhibition of JAK2 could not overcome GM-CSF-induced dissociation of the CBAP-bc complex (Supplementary Figure S5) . More experiments will be required to reveal the nature and 5) . At various times (0-20 min) after re-stimulation with GM-CSF, cell lysates were prepared and analysed by immunoblotting using antibodies specific to active form (phosphorylated, p) or all forms of JAK2, Stat5 or ERK1/2 as indicated. CBAP, common b-chain associated protein; GM-CSF, granulocyte-macrophage-colony stimulating factor; JAK, Janus kinase; siRNA, small interfering RNA; TNF, tumor necrosis factor. possible regulation of the hypothetical 'A' and 'P' type complexes.
The box 2 motif is highly conserved among multiple cytokine receptor family members. This raises the possibility that CBAP may also associate with such a motif in other cytokine receptors and transduces apoptotic signals in the absence of their cognate ligands. More experiments including generation of CBAP knockout mice will be required to test this possibility.
Materials and methods

CBAP-specific monoclonal antibody
The CBAP-specific mouse monoclonal antibody 5E1 was generated by standard protocol using bacterially produced recombinant full-length CBAP fused to GST (Genesis Biotech Inc., Taipei, Taiwan). Knock down of CBAP expression by siRNA TF-1 (5 Â 10 6 ) cells were electroporated with 0.5 nmol of double-stranded CBAP specific (siCBAP: 5 0 -GGACTTTGTC TTCTCTTTG-3 0 , siCBAP-2: 5 0 -ATCGCCTAGTGACGTTT CA-3 0 ) or control (catalog no. D-001210-01) siRNA (Dharmacon, Lafayette, CO, USA) using BioRad (Hercules, CA, USA) GenePulser at 250 V, 400 mF.
Expression vectors
Statistical analysis
Where applicable, the statistical significance of some experimental results (mean ± s.d., nX3) was analysed by unpaired Student's t-test. The Pp0.05 was considered to be statistically significant.
Other materials and methods
Additional information on yeast two-hybrid screen, confocal microscopy, apoptosis assays, cell culture and other materials used in this study is available as Supplementary Information on the Oncogene website.
